NCT05581043View on ClinicalTrials.gov

Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 12, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
KetosisPostprandial HyperglycemiaGlucose Metabolism Disorders (Including Diabetes Mellitus)
Interventions
DIETARY_SUPPLEMENT

3-hydroxybutyrate (3-OHB)

The aim of this study was therefore to i) investigate the dose/response relationship between 3-OHB servings of 0, 10, 20 and 40 grams 30 minutes before an OGTT and, ii) investigate the role of timing by serving 25 grams of 3-OHB at different timepoints ahead of an OGTT (0, 30 and 60 minutes).

Trial Locations (1)

8200

Department of Endocrinology and Internal Medicine, Aarhus

All Listed Sponsors
collaborator

Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark

UNKNOWN

collaborator

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark

UNKNOWN

lead

University of Aarhus

OTHER